As NICE explains how to apply its newly adopted, more sensitive value set for measuring quality of life in health technology ...
Zydus’ novel drug saroglitazar hit the primary endpoint in a Phase IIb trial for MASH but other key data are held back for a ...
The DC Circuit has upheld the DMCA exemption allowing independent technicians to access medical device software for diagnosis ...
Boston Scientific is recalling unused Infinion CX leads after reporting 1,081 serious injuries linked to electrical signal ...
The US FDA gave accelerated approval to the oral SERD for use in combination with CDK4/6 inhibitors among patients with ...
Janus 2.0 Commits 80% Of the Alliance for Regenerative Medicine's Efforts to Regulators and Payers and Is Explicit About What ...
Only a few hundred individuals in the US are diagnosed with the progressive neurological disease; Ionis will focus on ...
Patch supply has nearly doubled in a year, but demand surged after the agency told menopausal hormone therapy sponsors in ...
The FDA is seeking public input to modernize its regulatory framework for botanical drug products, spurred by growing ...
The BCMAxCD3-directed bispecific for myeloma would be late to the game, but it could address a significant uptake gap in ...
A core element of the contentious extended producer responsibility scheme under the EU's Urban Waste Water Treatment ...
An Advocate General has recommended that the European Court of Justice annul the provision requiring medicines and cosmetics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results